WALTHAM, Mass.--(BUSINESS WIRE)--
PerkinElmer,
Inc. (NYSE: PKI), a global leader committed to innovating for a
healthier world, today announced the upcoming retirement of Andy Wilson
(age 59), senior vice president and chief financial officer (CFO). To
provide appropriate time to identify a successor CFO and ensure a smooth
integration, Mr. Wilson - who has held his position since joining
PerkinElmer in 2009 - will retire in August 2018.
"The opportunity to serve in this role at PerkinElmer has been a
tremendous experience, and I am committed to playing an active role in
helping transition to our next CFO," Mr. Wilson said. "I have been
fortunate to work with a talented and dedicated team while helping lead
the organization during such a transformative time for PerkinElmer."
"I am grateful to Andy for his significant contributions to PerkinElmer
over the years," said Robert F. Friel, PerkinElmer's President and CEO.
"The progress we have made in refining our portfolio and improving our
financial returns during Andy's tenure has helped to position the
Company for accelerated growth and long-term success."
The Company has engaged an executive recruiting firm to assist in an
external search to fill the CFO position.
About PerkinElmer
PerkinElmer, Inc. is a global leader committed to innovating for a
healthier world. Our dedicated team of 9,000 employees worldwide is
passionate about providing customers with an unmatched experience as
they help solve critical issues especially impacting the diagnostics,
discovery and analytical solutions markets. Our innovative detection,
imaging, informatics and service capabilities, combined with deep market
knowledge and expertise, help customers gain earlier and more accurate
insights to improve lives and the world around us. The Company reported
revenue of approximately $2.1 billion in 2016, serves customers in more
than 150 countries, and is a component of the S&P 500 Index. Additional
information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, but not limited to, statements relating to estimates and
projections of future earnings per share, cash flow and revenue growth
and other financial results, developments relating to our customers and
end-markets, and plans concerning business development opportunities and
divestitures. Words such as "believes," "intends," "anticipates,"
"plans," "expects," "projects," "forecasts," "will" and similar
expressions, and references to guidance, are intended to identify
forward-looking statements. Such statements are based on management's
current assumptions and expectations and no assurances can be given that
our assumptions or expectations will prove to be correct. A number of
important risk factors could cause actual results to differ materially
from the results described, implied or projected in any forward-looking
statements. These factors include, without limitation: (1) markets into
which we sell our products declining or not growing as anticipated; (2)
fluctuations in the global economic and political environments; (3) our
failure to introduce new products in a timely manner; (4) our ability to
execute acquisitions and license technologies, or to successfully
integrate acquired businesses and licensed technologies into our
existing business or to make them profitable, or successfully divest
businesses; (5) our failure to adequately protect our intellectual
property; (6) the loss of any of our licenses or licensed rights; (7)
our ability to compete effectively; (8) fluctuation in our quarterly
operating results and our ability to adjust our operations to address
unexpected changes; (9) significant disruption in third-party package
delivery and import/export services or significant increases in prices
for those services; (10) disruptions in the supply of raw materials and
supplies; (11) the manufacture and sale of products exposing us to
product liability claims; (12) our failure to maintain compliance with
applicable government regulations; (13) regulatory changes; (14) our
failure to comply with healthcare industry regulations; (15) economic,
political and other risks associated with foreign operations; (16) our
ability to retain key personnel; (17) significant disruption in our
information technology systems; (18) our ability to obtain future
financing; (19) restrictions in our credit agreements; (20) the approval
of the Brexit Referendum in the United Kingdom; (21) our ability to
realize the full value of our intangible assets; (22) significant
fluctuations in our stock price; (23) reduction or elimination of
dividends on our common stock; and (24) other factors which we describe
under the caption "Risk Factors" in our most recent quarterly report on
Form 10-Q and in our other filings with the Securities and Exchange
Commission. We disclaim any intention or obligation to update any
forward-looking statements as a result of developments occurring after
the date of this press release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170915005805/en/
PerkinElmer, Inc.
Brian Willinsky, +1-781-663-5728
brian.willinsky@perkinelmer.com
Source: PerkinElmer, Inc.
News Provided by Acquire Media